Anesth Pain Med.  2018 Jan;13(1):40-46. 10.17085/apm.2018.13.1.40.

Sugammadex use can decrease the incidence of post-operative urinary retention by avoiding anticholinergics: a retrospective study

• Cha JE
• Park SW
• Choi YI
• Oh ID
• Kang HY
• Lee SH
• Choi JH

• KMID: 2436054
• DOI: http://doi.org/10.17085/apm.2018.13.1.40

Abstract

BACKGROUND
Postoperative urinary retention (POUR) is a common complication after total knee arthroplasty (TKA) and associated with the use of anticholinergics. The introduction of sugammadex has decreased perioperative use of anticholinergics. Since anticholinergics may influence the detrusor muscle, the purpose of this study was to compare incidence of POUR between sugammadex and anticholinergic use for reversal of muscle relaxant.
METHODS
This study was a retrospective cohort study in a university-affiliated hospital. A total of 571 patients who underwent TKA between 2015 and 2016 with an American Society of Anesthesiologists class ≤ 3 were included in this study. Patients who received sugammadex (group S, n = 208) were compared to those who received glycopyrrolate with pyridostigmine (group C, n = 363) for reversal of neuromuscular blockade. The primary outcome was the incidence of POUR. Secondary outcomes were hospital length of stay (HOS) and daily residual urine drained from intermittent catheterization. Demographic, intraoperative, and laboratory data were collected.
RESULTS
The incidence of POUR was significantly lower in group S compared to group C (36.1 vs. 48.8%, P = 0.003). On post-operative day (POD) 0, there was no significant difference in the residual urine volume between the two groups. However, from POD 1 to POD 4, the residual urine volume was significantly lower in group S compared to group C. There was no significant difference in HOS between the two groups.
CONCLUSIONS
The use of sugammadex was associated with a lower incidence of POUR by avoiding glycopyrrolate in patients underwent TKA.

Keyword

Arthroplasty; replacement; knee; Cholinergic antagonists; Urinary retention

MeSH Terms

Arthroplasty
Arthroplasty, Replacement, Knee
Catheterization
Catheters
Cholinergic Antagonists*
Cohort Studies
Glycopyrrolate
Humans
Incidence*
Knee
Length of Stay
Neuromuscular Blockade
Pyridostigmine Bromide
Retrospective Studies*
Urinary Retention*
Cholinergic Antagonists
Glycopyrrolate
Pyridostigmine Bromide

Reference

1. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med. 2000; 154:1214–8. DOI: 10.1001/archpedi.154.12.1214. PMID: 11115305.

2. Tammela T, Kontturi M, Lukkarinen O. Postoperative urinary retention. I. Incidence and predisposing factors. Scand J Urol Nephrol. 1986; 20:197–201. DOI: 10.3109/00365598609024494. PMID: 3787196.

3. Brouwer TA, Eindhoven BG, Epema AH, Henning RH. Validation of an ultrasound scanner for determing urinary volumes in surgical patients and volunteers. J Clin Monit Comput. 1999; 15:379–85. DOI: 10.1023/A:1009939530626. PMID: 12578033.

4. Kumar P, Mannan K, Chowdhury AM, Kong KC, Pati J. Urinary retention and the role of indwelling catheterization following total knee arthroplasty. Int Braz J Urol. 2006; 32:31–4. DOI: 10.1590/S1677-55382006000100005. PMID: 16519825.

5. Irvine R, Johnson BL Jr, Amstutz HC. The relationship of genitourinary tract procedures and deep sepsis after total hip replacements. Surg Gynecol Obstet. 1974; 139:701–6. PMID: 4215168.

6. Lee S, Kim CH, Chung CK, Park SB, Yang SH, Kim SH, et al. Risk factor analysis for postoperative urinary retention after surgery for degenerative lumbar spinal stenosis. Spine J. 2017; 17:469–77. DOI: 10.1016/j.spinee.2016.03.017. PMID: 27012647.

7. Lau H, Lam B. Management of postoperative urinary retention: a randomized trial of in-out versus overnight catheterization. ANZ J Surg. 2004; 74:658–61. DOI: 10.1111/j.1445-1433.2004.03116.x. PMID: 15315566.

8. Toyonaga T, Matsushima M, Sogawa N, Jiang SF, Matsumura N, Shimojima Y, et al. Postoperative urinary retention after surgery for benign anorectal disease: potential risk factors and strategy for prevention. Int J Colorectal Dis. 2006; 21:676–82. DOI: 10.1007/s00384-005-0077-2. PMID: 16552523.

9. Verhamme KM, Sturkenboom MC, Stricker BH, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008; 31:373–88. DOI: 10.2165/00002018-200831050-00002. PMID: 18422378.

10. Petros JG, Rimm EB, Robillard RJ. Factors influencing urinary tract retention after elective open cholecystectomy. Surg Gynecol Obstet. 1992; 174:497–500. PMID: 1350689.

11. Petros JG, Mallen JK, Howe K, Rimm EB, Robillard RJ. Patient-controlled analgesia and postoperative urinary retention after open appendectomy. Surg Gynecol Obstet. 1993; 177:172–5. PMID: 8342098.

12. Welliver M, McDonough J, Kalynych N, Redfern R. Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent. Drug Des Devel Ther. 2009; 2:49–59. PMID: 19920893. PMCID: PMC2761174.

13. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg. 2007; 104:575–81. DOI: 10.1213/01.ane.0000244594.63318.fc. PMID: 17312211.

14. Lee S. What anesthesiologists ask to know and should know about the neuromuscular monitoring: an updated review. Anesth Pain Med. 2017; 12:1–8. DOI: 10.17085/apm.2017.12.1.1.

15. Pavlin DJ, Pavlin EG, Gunn HC, Taraday JK, Koerschgen ME. Voiding in patients managed with or without ultrasound monitoring of bladder volume after outpatient surgery. Anesth Analg. 1999; 89:90–7. DOI: 10.1097/00000539-199907000-00016. PMID: 10389784.

16. Balderi T, Carli F. Urinary retention after total hip and knee arthroplasty. Minerva Anestesiol. 2010; 76:120–30. PMID: 20150853.

17. Lamonerie L, Marret E, Deleuze A, Lembert N, Dupont M, Bonnet F. Prevalence of postoperative bladder distension and urinary retention detected by ultrasound measurement. Br J Anaesth. 2004; 92:544–6. DOI: 10.1093/bja/aeh099. PMID: 14977795.

18. Keita H, Diouf E, Tubach F, Brouwer T, Dahmani S, Mantz J, et al. Predictive factors of early postoperative urinary retention in the postanesthesia care unit. Anesth Analg. 2005; 101:592–6. table of contents. DOI: 10.1213/01.ANE.0000159165.90094.40. PMID: 16037182.

19. Husted S, Djurhuus JC, Husegaard HC, Jepsen J, Mortensen J. Effect of postoperative extradural morphine on lower urinary tract function. Acta Anaesthesiol Scand. 1985; 29:183–5. DOI: 10.1111/j.1399-6576.1985.tb02182.x. PMID: 3976331.

20. Baldini G, Bagry H, Aprikian A, Carli F. Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology. 2009; 110:1139–57. DOI: 10.1097/ALN.0b013e31819f7aea. PMID: 19352147.

21. Marinkovic SP, Badlani G. Voiding and sexual dysfunction after cerebrovascular accidents. J Urol. 2001; 165:359–70. DOI: 10.1097/00005392-200102000-00003.

22. Malinovsky JM, Le Normand L, Lepage JY, Malinge M, Cozian A, Pinaud M, et al. The urodynamic effects of intravenous opioids and ketoprofen in humans. Anesth Analg. 1998; 87:456–61. DOI: 10.1213/00000539-199808000-00042. DOI: 10.1097/00000539-199808000-00042. PMID: 9706950.

23. Stallard S, Prescott S. Postoperative urinary retention in general surgical patients. Br J Surg. 1988; 75:1141–3. DOI: 10.1002/bjs.1800751128. PMID: 3208051.